1. Udoji, MA, Ness, TJ. New directions in the treatment of pelvic pain. Pain Manag 2013; 3: 387–394.
Google Scholar | Crossref | Medline2. Manzanares, J, Julian, M, Carrascosa, A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol 2006; 4: 239–257.
Google Scholar | Crossref | Medline3. Hohmann, AG, Herkenham, M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 1999; 90: 923–931.
Google Scholar | Crossref | Medline4. Pernía-Andrade, AJ, Kato, A, Witschi, R, et al. Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science 2009; 325:760–764.
Google Scholar | Crossref | Medline5. Zhang, G, Chen, W, Lao, L, et al. Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization. Eur J Neurosci 2010; 31: 225–237.
Google Scholar | Crossref | Medline6. Bridges, D, Rice, ASC, Egertová, M, et al. Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience 2003; 119: 803–812.
Google Scholar | Crossref | Medline7. Resuehr, D, Glore, DR, Taylor, HS, et al. Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Fertil Steril 2012; 98: 948–956.e1.
Google Scholar | Crossref | Medline8. Peralta, L, Agirregoitia, E, Mendoza, R, et al. Expression and localization of cannabinoid receptors in human immature oocytes and unfertilized metaphase-II oocytes. Reprod Biomed Online 2011; 23: 372–379.
Google Scholar | Crossref | Medline9. Muller, C, Morales, P, Reggio, PH. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci 2018; 11: 487.
Google Scholar | Crossref | Medline10. Console-Bram, L, Marcu, J, Abood, ME. Cannabinoid receptors: nomenclature and pharmacological principles. Prog Neuropsychopharmacol Biol Psychiatry 2012; 38: 4–15.
Google Scholar | Crossref | Medline11. Atalay, S, Jarocka-Karpowicz, I, Skrzydlewska, E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants 2019; 9: 21.
Google Scholar | Crossref | Medline12. Small-Howard, AL, Shimoda, LMN, Adra, CN, et al. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. Biochem J 2005; 388: 465–473.
Google Scholar | Crossref | Medline13. Ibrahim, MM, Porreca, F, Lai, J, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 2005; 102: 3093–3098.
Google Scholar | Crossref | Medline14. Pisanti, S, Borselli, C, Oliviero, O, et al. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. J Cell Physiol 2007; 211: 495–503.
Google Scholar | Crossref | Medline15. Leconte, M, Nicco, C, Ngô, C, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol 2010; 177: 2963–2970.
Google Scholar | Crossref | Medline16. Klein, TW, Newton, C, Larsen, K, et al. The cannabinoid system and immune modulation. J Leukoc Biol 2003; 74: 486–496.
Google Scholar | Crossref | Medline17. Silvestri, C, Ligresti, A, Di Marzo, V. Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle. Rev Endocr Metab Disord 2011; 12: 153–162.
Google Scholar | Crossref | Medline18. Farkas, I, Kalló, I, Deli, L, et al. Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology 2010; 151: 5818–5829.
Google Scholar | Crossref | Medline19. Rodríguez, de, Fonseca, F, Cebeira, M, Ramos, JA, et al. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci 1994; 54: 159–170.
Google Scholar | Crossref | Medline20. Fattore, L, Spano, MS, Altea, S, et al. Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br J Pharmacol 2007; 152: 795–804.
Google Scholar | Crossref | Medline21. Craft, RM, Marusich, JA, Wiley, JL. Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system? Life Sci 2013; 92: 476–481.
Google Scholar | Crossref | Medline22. Vallée, M, Vitiello, S, Bellocchio, L, et al. Pregnenolone can protect the brain from cannabis intoxication. Science 2014; 343: 94–98.
Google Scholar | Crossref | Medline23. Daniel, JM, Winsauer, PJ, Brauner, IN, et al. Estrogen improves response accuracy and attenuates the disruptive effects of delta9-THC in ovariectomized rats responding under a multiple schedule of repeated acquisition and performance. Behav Neurosci 2002; 116: 989–998.
Google Scholar | Crossref | Medline24. Scorticati, C, Fernandez-Solari, J, De Laurentiis, A, et al. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proc Natl Acad Sci USA 2004; 101: 11891–11896.
Google Scholar | Crossref | Medline25. Dalterio, SL, Mayfield, DL, Bartke, A. Effects of delta 9-THC on plasma hormone levels in female mice. Subst Alcohol Actions Misuse 1983; 4: 339–345.
Google Scholar | Medline26. Tyrey, L. Delta-9-tetrahydrocannabinol suppression of episodic luteinizing hormone secretion in the ovariectomized rat. Endocrinology 1978; 102: 1808–1814.
Google Scholar | Crossref | Medline27. Asch, RH, Smith, CG, Siler-Khodr, TM, et al. Effects of delta 9-tetrahydrocannabinol during the follicular phase of the rhesus monkey (Macaca mulatta). J Clin Endocrinol Metab 1981; 52: 50–55.
Google Scholar | Crossref | Medline28. Asch, RH, Smith, CG, Siler-Khodr, TM, et al. Effects of delta 9-tetraphydrocannabinol administration on gonadal steroidogenic activity in vivo. Fertil Steril 1979; 32: 576–582.
Google Scholar | Crossref | Medline29. Almirez, RG, Smith, CG, Asch, RH. The effects of marijuana extract and delta 9-tetrahydrocannabinol on luteal function in the rhesus monkey. Fertil Steril 1983; 39: 212–217.
Google Scholar | Crossref | Medline30. Smith, CG, Almirez, RG, Berenberg, J, et al. Tolerance develops to the disruptive effects of delta 9-tetrahydrocannabinol on primate menstrual cycle. Science 1983; 219: 1453–1455.
Google Scholar | Crossref | Medline31. Scotchie, JG, Savaris, RF, Martin, CE, et al. Endocannabinoid regulation in human endometrium across the menstrual cycle. Reprod Sci 2015; 22: 113–123.
Google Scholar | SAGE Journals32. Jukic, AMZ, Weinberg, CR, Baird, DD, et al. Lifestyle and reproductive factors associated with follicular phase length. J Womens Health (Larchmt) 2007; 16: 1340–1347.
Google Scholar | Crossref | Medline33. Baumann, R, Kuhl, H, Taubert, HD, et al. Ovulation inhibition by daily i.m. administration of a highly active LH-RH analog (d-ser(TBU)6-LH-RH-(1-9)-nonapeptide-ethylamide). Contraception 1980; 21: 191–197.
Google Scholar | Crossref | Medline34. Lammert, S, Harrison, K, Tosun, N, et al. Menstrual cycle in women who co-use marijuana and tobacco. J Addict Med 2018; 12: 207–211.
Google Scholar | Crossref | Medline35. Mendelson, JH, Mello, NK, Ellingboe, J, et al. Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther 1986; 237: 862–866.
Google Scholar | Medline36. Griffin, ML, Mendelson, JH, Mello, NK, et al. Marihuana use across the menstrual cycle. Drug Alcohol Depend 1986; 18: 213–224.
Google Scholar | Crossref | Medline37. Lex, BW, Mendelson, JH, Bavli, S, et al. Effects of acute marijuana smoking on pulse rate and mood states in women. Psychopharmacology 1984; 84: 178–187.
Google Scholar | Crossref | Medline38. Luschnig, P, Schicho, R. Cannabinoids in gynecological diseases. Med Cannabis Cannabinoids 2019; 2: 14–21.
Google Scholar | Crossref39. Juan, C-C, Chen, K-H, Wang, P-H, et al. Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2015; 104: 200–206.
Google Scholar | Crossref | Medline40. Cui, N, Feng, X, Zhao, Z, et al. Restored plasma anandamide and endometrial expression of fatty acid amide hydrolase in women with polycystic ovary syndrome by the combination use of diane-35 and metformin. Clin Ther 2017; 39: 751–758.
Google Scholar | Crossref | Medline41. Ahangari, A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician 2014; 17: E141–E147.
Google Scholar | Crossref | Medline42. Cagnacci, A, Della Vecchia, E, Xholli, A. Chronic pelvic pain improvement: impact on quality of life and mood. Gynecol Endocrinol 2019; 35: 502–505.
Google Scholar | Crossref | Medline43. Mathias, SD, Kuppermann, M, Liberman, RF, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996; 87: 321–327.
Google Scholar | Crossref | Medline44. Howard, FM. The role of laparoscopy in chronic pelvic pain: promise and pitfalls. Obstet Gynecol Surv 1993; 48:357–387.
Google Scholar | Crossref | Medline45. Merrill, RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 2008; 14: CR24–CR31.
Google Scholar46. Peters, KM, Carrico, DJ, Ibrahim, IA, et al. Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome. Urology 2008; 71: 634–640.
Google Scholar | Crossref | Medline47. Passavanti, MB, Pota, V, Sansone, P, et al. Chronic pelvic pain: assessment, evaluation, and objectivation. Pain Res Treat 2017; 2017: 1–15.
Google Scholar | Crossref48. Carrubba, AR, Spaulding, AC, Ebbert, JO, et al. Patient-reported use of medical cannabis for management of chronic pelvic pain [12H]. Obstet Gynecol 2020; 135: 84S.
Google Scholar | Crossref49. Johns, C, Lachiewicz, M. Cannabis for treatment of chronic pelvic pain: a survey of prevalence and effectiveness [21H]. Obstet Gynecol 2019; 133: 90S.
Google Scholar | Crossref50. Cosar, E, Güngör, AC, Gencer, M, et al. Sleep disturbance among women with chronic pelvic pain. Int J Gynaecol Obstet 2014; 126: 232–234.
Google Scholar | Crossref | Medline51. Finan, PH, Goodin, BR, Smith, MT. The association of sleep and pain: an update and a path forward. J Pain 2013; 14: 1539–1552.
Google Scholar | Crossref | Medline52. Russo, EB, Guy, GW, Robson, PJ. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex®, a cannabis-based medicine. C&B